Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Keytruda

May 31, 2022

Bristol-Myers Squibb’s Opdivo Approval; Mirati’s KRAS-inhibitor Adagrasib; J&J and Legend Biotech’s CAR-T Carvykti Approval; Roche’s Glofitamab; Arena Pharma’s Etrasimod Phase 3 Trials; FDA Approves Dermavant’s Vtama; FDA Approves Novartis’ Cell Therapy; NICE Approves Merck’s Keytruda

Jan 10, 2022

Novel and Emerging Metastatic Colorectal Cancer Treatment Drugs Anticipated to Change Market Dynamics

Jun 05, 2020

Prostate Cancer Market Experiences an Influx of the Pharma Players Veering the Market Ahead

Jan 15, 2020

Malignant Pleural Mesothelioma Upcoming Therapies

May 23, 2019

The Business Cocktail

May 02, 2019

The Business Cocktail

Apr 23, 2019

Notizia

Nov 12, 2018

Virus, the Cancer Therapy of the Future

Mar 22, 2018

Business Cocktail

Oct 10, 2017

Novo petitions FDA;J&J invests; Xarelto’s trial; Roche’s Tecentriq

Newsletter/Whitepaper